ContentslistsavailableatScienceDirect
Journal
of
Cardiology
j ou rn a l h o m ep a g e :w w w . e l s e v i e r . c o m / l o c a t e / j j c c
Review
Syncope:
Classification
and
risk
stratification
Venkata
Krishna
Puppala
(MD),
Oana
Dickinson
(MD),
David
G.
Benditt
(MD)
∗ TheCardiacArrhythmiaCenter,UniversityofMinnesotaMedicalSchool,Minneapolis,MN,USAa
r
t
i
c
l
e
i
n
f
o
Articlehistory:
Received19March2013 Accepted22March2013 Availableonline7January2014
Keywords:
Syncope Riskstratification
Transientlossofconsciousness Syncopeclinic
a
b
s
t
r
a
c
t
Background:Syncopeisoneofthemostcommonreasonsforemergencydepartmentandurgentcare
clinicvisits.Themanagementofsyncopecontinuestobeachallengingproblemforfront-lineproviders inasmuchasthereareamultitudeofpossiblecausesforsyncoperangingfromrelativelybenignconditions topotentiallylife-threateningones.Inanyevent,itisimportanttoidentifythosesyncopepatientswho areatimmediateriskoflife-threateningevents;theseindividualsrequireprompthospitalizationand thoroughevaluation.Conversely,itisequallyimportanttoavoidunnecessaryhospitalizationoflow-risk patientssinceunneededhospitalcareaddstothehealthcarecostburden.
Results:Historically,front-lineprovidershavetakenaconservativeapproachwithadmissionratesashigh
as30–50%amongsyncopepatients.Anumberofstudiesevaluatingboththeshort-andlong-termrisk ofadverseeventsinpatientswithsyncopehavefocusedondevelopmentofrisk-stratificationguidelines toassistprovidersinmakingaconfidentandwell-informedchoicebetweenhospitalizationand out-patientreferral.Inthisregard,amuchneededconsensusonoptimaldecision-makingprocesshasnot beendevelopedtodate.However,knowledgefromvariousavailablerisk-stratificationstudiescanbe helpful.
Conclusion:Thisreviewsummarizesthefindingsofvariousrisk-stratificationstudiesandpointsout
keydifferencesbetweenthem.While,theexistingrisk-stratificationmethodscannotreplacecritical assessmentbyanexperiencedphysician,theydoprovidevaluableguidance.Inaddition,thevarious risk-assessmentschemeshighlighttheneedforcarefulinitialclinicalassessmentofsyncopepatients, selectivetesting,andbeingmindfuloftheshort-andlong-termrisks.
©2014JapaneseCollegeofCardiology.PublishedbyElsevierLtd.Allrightsreserved.
Contents
Introduction... 172
Classificationofsyncope... 172
Neurally-mediatedsyncope(alsotermedneuralreflexsyncope)... 172
Orthostatichypotension ... 172
Syncopeduetocardiacarrhythmias... 172
Syncopeduetostructuralcardiacdisease... 173
Syncopesecondarytocerebrovascularcauses... 173
Syncopemimics... 173
Riskstratificationofsyncope... 173
Short-termorimmediaterisk... 174
High-riskmarkersofshort-termadverseoutcomes... 175
Long-termrisk... 175
Riskstratificationbasedoncardiacversusnon-cardiaccausesofsyncope... 175
Issyncopeamarkerofincreasedriskofcardiovascularmorbidityandmortality?... 176
Conclusion... 176
Acknowledgment... 176
References... 177
∗Correspondingauthorat:TheCardiacArrhythmiaCenter,UniversityofMinnesotaMedicalSchool,MMC508,420DelawareStreetSE,Minneapolis,MN55455,USA. Tel.:+16126254401;fax:+16126244937.
E-mailaddress:[email protected](D.G.Benditt).
0914-5087/$–seefrontmatter©2014JapaneseCollegeofCardiology.PublishedbyElsevierLtd.Allrightsreserved.
Introduction
Syncopeisasyndromecharacterizedbyatransientself-limited episodeoflossofconsciousnessoccurringasaresultofabrief inter-ruptionofoxygensupplytothebrain.Thisinterruptionofcerebral nutrientflowinasyncopaleventisalmostalwaysduetotransient cessationofblood flow[1,2].Atransientreversibledropin sys-temicarterialbloodpressuretoalevelbelowthatneededtosustain cerebralperfusionisthemostcommoncauseofsyncope.Other possibilitiesarerare,and includeacutehypoxemia (e.g.aircraft decompression)ormajormetabolicdisturbanceaffectingneuronal pathways.
Sincetransientglobalcerebralhypoperfusionisthesinequanon ofsyncopepathophysiology,othercausesoflossofconsciousness shouldnotbeclassifiedas‘syncope’.Thusseizures,concussions, hypoglycemia,andothernon-perfusionrelateddisturbancesare separatediagnosticissues;thesearenon-syncopecausesof tran-sientlossofconsciousness(TLOC)[1,3].
Intruesyncope,theepisodeischaracterizedbyarapidonset oflossofconsciousnesswithorwithoutanywarningsymptoms. Evenwhenwarningsymptomsarepresentbeforesyncope,lossof consciousnessusuallyoccurswithin10–20softheironset. Recov-eryistypicallypromptandcompletewithoutanyneedformedical interventionandwithoutanynewresidualneurologicfindings. Classificationofsyncope
Theclassificationofsyncopeismainlybasedontheunderlying mechanismsthatleadtothefinaleventoftransientglobal hypo-perfusion.Thediagnosticclassificationofthecausesofsyncope modifiedfromtheEuropeanSocietyofCardiology(ESC)syncope practiceguidelines[1]issummarizedinTable1.
Neurally-mediatedsyncope(alsotermedneuralreflexsyncope)
Thistypeofsyncopeincludesanumberofconditions.Themost importantandalsothemostcommonwithinthiscategoryis vaso-vagalsyncope.Thesecondmostcommoniscarotidsinussyncope (CSS)whichmostlyoccursintheelderlyandprimarilyinmen[3–6]. Carotidsinushypersensitivity(CSH)isaclinicalfindingelicitedby massagingthecarotidsinus.CSHshouldbedistinguishedfromCSS astheformerisaclinicalfindingandthelatterisaclinical mani-festation.CSSisonlydiagnosedifcarotidmassagecausessufficient bradycardia(usually>6s)and/orhypotensiontocause reproduc-tionofthepatients’symptoms.
Situationalsyncopeisathirdcategoryofreflexfaint;itincludes syncopetriggeredbyanyofanumberofactivitiessuchas: mic-turition,defecation,coughing,orswallowing.Theinitialevent(e.g. micturition)triggers [1,3]eithera slowheart rateordepressed vasculartone(orboth)that resultsinsufficient hypotensionto causetransientcerebralhypoperfusionandultimatetransient self-limitedepisodeoflossofconsciousness.Insomecases(e.g.cough syncope,trumpet-blowerssyncope),transientvenousobstruction duetoincreasedintra-thoracicpressuremaycontributetocerebral hypoperfusion.
Orthostatichypotension
Orthostaticsyncopeoccursasresultofthebody’sinabilityto maintainbloodpressureadequateforcerebralperfusionwhenthe individualmovestotheuprightposture,andwhichinturnresults inTLOC[1,7,8].Thechangeinposturefromlyingdowntoanupright positionresultsinshiftofasmuchas500–1000mLofbloodaway fromthechesttovenouscapacitancesystembelowthediaphragm; thisshiftinturnresultsindiminishedvenousreturntoheartand
Table1
ThediagnosticclassificationofthecausesofsyncopemodifiedfromtheEuropean SocietyofCardiologysyncopepracticeguidelines.
Reflex(neurally-mediated)syncope
Vasovagal:
-triggeredbyemotionaldistress -triggeredbyorthostaticstress Situational:
-cough,sneeze
-gastrointestinalstimulation -micturition
-others
Carotidsinussyncope
Orthostatichypotensionsyncope
Volumedepletion:
-inadequatefluidintake(hotweather),diarrhea,vomiting,etc. Drug-inducedorthostatichypotension:
-alcohol,vasodilators,diuretics,beta-adrenergicblockers Primaryautonomicfailure:
-pureautonomicfailure,multiplesystematrophy,Parkinson’sdiseasewith autonomicfailure,Lewybodydementia
Secondaryautonomicfailure:
-diabetes,amyloidosis,spinalcordinjuries
Cardiacsyncope(cardiovascular)
Arrhythmiaasprimarycause: Bradycardia:
-sinusnodedysfunction,atrioventricularconductionsystemdisease -implanteddevicemalfunction
Tachycardia:
-supraventricularincludingatrialfibrillation
-ventricular(idiopathicsecondarytostructuralheartdisease,ordueto channelopathies)
Structuraldisease:
-Cardiac:cardiacvalvulardisease,acutemyocardialinfarction/ischemia, hypertrophiccardiomyopathy,cardiacmasses(atrialmyxoma,tumors,etc.), pericardialdisease/tamponade,congenitalanomaliesofcoronaryarteries, prostheticvalvesdysfunction
-Othercardiovascular:pulmonaryembolus/hypertension,acuteaortic dissection
consequentreductionofcardiacfillingpressureandstrokevolume leadingtohypotensionandcerebralhypoperfusion.
Thehumanbodyhasphysiologicaldefensesagainstorthostatic hypotensive episodes. These include a reflex increase in heart rate,reflexarterialandvenousvasoconstriction(especiallyinthe splanchnicbedandlowerextremities),andneuroendocrine adjust-ments(activationofrenin–angiotensin–aldosterone system)[7]. Allofthesedefensespreventhealthyindividualsfromhavinga syn-copalevent.However,incertainsituationsthesedefensescouldbe undermined.Forexample,superimposedvolumedepletionorloss ofimpairedcardiacresponseduetochronotropicincompetence,or impairedreflexvasoconstrictionduetoautonomicdysfunctionor medications(e.g.beta-blockers,etc.),orlossofskeletalmuscletone whichiscommonintheelderly,maycausereducedvenousreturn. Theindividualasaresultofsyncopewillslumptogravitationally neutral positionwhich usually resultsin promptresumptionof cerebralperfusion.Physicalcounterpressuremaneuverssuchas leg-crossingandmusclestraininghavebeenfoundtobehelpful inincreasingvenousreturnbyenhancingmusclepumpactivity [1].
Syncopeduetocardiacarrhythmias
Cerebralhypoperfusionresultinginsyncopecanoccurdueto eitherbrady-ortachy-arrhythmias.Bradycardiaisthemore com-mon;in thiscategory,symptomatic hypotensioncanoccurasa resultofsinuspauses,high-gradeatrioventricularblockorasystole thatoccursattheterminationofanatrialarrhythmia(particularly attheendofanepisodeofatrialfibrillation).Cardiacpacemaker placementishelpfulinpreventingthesebradycardiacepisodes.
Bothsupraventricularandventriculartachyarrhythmiasmaybe responsiblefortriggeringsyncope.Neurally-mediatedhypotension mayalsocontributeinthesepatients.Patientswithautonomic dys-functionareatgreatestriskforarrhythmia-relatedsyncopesince protectivereflexesthataresupposedtobeineffecttocounterthe tachycardicstressareabsentoraretoosluggish.
The occurrence of syncope due to ventricular tachyarrhyth-mias in patients with poor left ventricular function or due to channelopathy(i.e.longQTsyndrome,catecholaminergic parox-ysmal ventriculartachycardia, Brugadasyndrome) is predictive of increasedrisk of mortality due tosudden cardiac death[9]. Therefore, these patientswhen identified need to bepromptly referredtocardiacelectrophysiologyforfurtherevaluation;most willwarrantplacementofanimplantablecardioverter defibrilla-tor(ICD)andsomemaybecandidatesformappingandablation therapy.
Syncopeduetostructuralcardiacdisease
Althoughinfrequent, syncope can occurasa resultof acute myocardialinfarctionorpulmonaryembolism.Reducedstroke vol-umeistheunderlyingmechanismforcerebralhypoperfusionin thesecases,althoughneural-reflexfactorsmaycontribute, espe-ciallyinthecaseofacutemyocardialischemia.Valvular/structural heartdisease(e.g.severeaorticstenosis, severemitralstenosis, and large left atrial myxoma) can cause syncope. The cerebral hypoperfusion inthesesituations is oftena resultof thedirect hemodynamicimpactofananatomicalanomalyaswellas neurally-mediatedreflexesorlackofthem.Inpatientswithsevereaortic stenosis,inappropriatevasodilatationwithexertionisanaccepted basisforsymptomatichypotensionresultinginsyncope[10].
Syncopesecondarytocerebrovascularcauses
Thebrainiswellprotectedwithmultiplebloodvessels feed-ingtheCircleofWillisandthereforetruesyncopealmostnever occursasadirectresultofcerebrovasculardiseasealone.However, althoughrare,atransientischemicattackinthevertebrobasilar dis-tributionmaycausesyncope.Thepresenceofposteriorcirculation symptomssuchaslossofbalanceandvertigomakestheseevents distinguishablefromothercausesofsyncope.
Stealsyndromeassociatedwithsubclavianstenosisisanother rareconditionthatcanresultinsymptomsofsyncope,dizziness, vertigo,ornystagmusespecially withvigorous useofipsilateral armmuscles.Syncopeasasolitarymanifestationofthiscondition isextremelyrare[11].
Syncopemimics
TLOCcanoccurinavarietyofsituationssuchasseizures, concus-sions,orintoxication.However,asnotedearlier,thesearenottrue syncopaleventsasthebasisisnotcerebralhypoperfusion.They arebeingmentionedhereduetothediagnosticconfusionthatthey maycause.
Psychogenic pseudosyncope (oftentermedpseudoseizureby neurologistsespeciallyifjerkymusclemovementsaccompanythe collapse)isthemostcommonconditioninthesyncopemimics cat-egory.Itmaybedifficulttodistinguishthese‘pseudo’episodesfrom true syncope. However, pseuodosyncope/pseudoseizures most oftenwilloccurseveraltimesadaywhichalmostneverhappens inthecaseoftruesyncope.Tilt-tabletestingmaybehelpfulnot onlyinidentifyingthesepatients,butalsomaypermitdiscussing thediagnosisfranklywiththesepatients[12].
TLOCcanalso occurin casesof cataplexy and certaintypes ofakinetic orminimallykineticseizures[13].In elderlypeople,
accidentalfallsmaycauseTLOCduetoconcussion.Thediagnostic confusion caused by the above-mentioned conditions can be clearedbycarefulattentiontohistorytaking,butanexperienced clinicianisusuallyessential.Whenuncertaintypersists,the place-mentofexternalorimplantablelooprecordersmaybehelpfulto distinguishtheseconditionsfromtruesyncope.
Riskstratificationofsyncope
Syncopeisachallengingsymptomforthefirstcontactprovider [usuallyanemergencydepartment(ED)orurgentcarephysician] todealwith.First,thepatienthasusuallyrecovered,sothereareno clearphysicalfindingstosuggestacause.Second,therearesomany possiblecausestoconsider.Third,thepatientorwitnesses(ifany) mayhavebeensosurprisedbytheunexpectedevent,thatdetailed historical findings are not clearly recollected. Finally, the time availableinanEDtoundertakeadetailedassessmentislimited.
Syncopeisnottypically alife-threateningconditionbyitself (althoughtheunderlyingcausemaybe).However,syncopemay resultinuntowardconsequencessuchasphysicalinjuryand dimin-ishedqualityoflife.Syncopemayalsobeanindicatorofpotentially life-threateningunderlyingconditions;forinstance,severe struc-turalheart diseasewithconsequentmalignant arrhythmiasand heartfailure.
Aconfidentdiagnosisofthecauseofasyncopeeventmayor maynotbemadeinEDorclinic.IncaseswherethecauseofTLOC isestablishedwithcertaintyduringinitialevaluation,the subse-quentcourseofactionisclear.However,moreoftenthediagnosisis unclearandtheresponsibleprovidersarefacedwiththedilemmaof choosingbetweenimmediatehospitalizationversustimely outpa-tientevaluation.Physicianshistoricallyhavefavoredaconservative courseofactionresultinginmanymorepatientsbeingadmittedto hospitalthaniswarranted.
The ESC Syncope Task Force provided guidelines for front-line providers to use for assessing patients presenting with TLOC/collapse/syncopeandtherebyarriveatadecisionbetween inpatientversusoutpatientevaluation.
Fig.1providesanoverviewofanapproachtoassessmentofa patientwhopresentswithTLOC/collapsebasedontheESCSyncope TaskForceGuidelines[1].
Atthepresenttime,despitetutoringthephysiciansinESC guide-lines,highadmissionratesappeartopersist(ashighas30–50%per
Fig.1.Flowchartfordiagnosticevaluationofpatientswhopresenttotheemergency department(ED)orclinicwithtransientlossofconsciousness(TLOC)/syncope. ModifiedafterRef.[1].
variousreports).Bywayofexample,Bartolettietal.[14]examined admissionratesamongpatientsreferredtoEDwithsyncope.The studywasbasedonESCguidelinesformanagementofsyncope[1]. Atotalof1124patientswereevaluatedand400(39.1%)ofthem metatleastonecriterionforadmissionperESCguidelinesand680 (60.9%)didnotmeetanycriteria.Theactualadmissionrateswere 89.3%amongpatientswithindicationand25.3%amongthose with-outanyindication.Thehighadmissionratesamongthelow-risk patientsareindicativeofphysicianconcernforpatientsafetyafter discharge.SimilarfindingswerenotedinEGSYS2study[15]where theadmissionratewasnotedtobeashighas39%despiteproviding expertonlineassistancetothefront-linephysicians.The unneces-saryinpatientadmissionoflow-riskpatientsnotonlyaddstothe costofcarebutalsomaynotimprovepatientsafetyordiagnostic outcomes.
RiskstratificationofTLOC/syncopepatientshasbeenthe sub-jectofseveralrecenttrialswiththeobjectivebeingabletoderive effectivecriteriatohelpchoosebetweeninpatientadmissionand outpatientsyncopeclinicreferral[16].Themostimportant objec-tivesofrisk-stratificationstudiesaretoassesstheimmediateor short-term(1weekto1month)andlonger-term(approximately1 year)riskof:
1)Deathorlife-threateningevents.
2)Recurrenceofsyncopalevents,whichinturnmayleadto phys-icalinjury,disability,ordiminishedqualityoflife.
Althoughaconsensusrisk-stratificationtoolisnotyetavailable, suchatool-setwouldhopefullyhelpEDorclinicphysicians deter-minetheimmediateriskofadverseeventsandifriskisdeemedto behigh,itshouldpromptthephysiciantoadmittothehospitalfor furtherevaluation[16].Incaseswheretheriskisfelttobe inter-mediate,oneshouldconsiderplacementofthepatientinasyncope observationunitifavailable,aswasdoneintheSEEDSstudy[17]. Intheabsenceofimmediateorshort-termriskbasedonsucha tool,thepatientsmaybereferredforoutpatientevaluation prefer-ablyinaclinicdedicatedforevaluationofpatientswithsyncopeor TLOC.Insomesituations,thepresenceofriskfactorsforincreased long-termriskoflife-threateningevents,patientsmayneed hospi-talizationforfurtherassessment.Severalclinicalstudiesfocuson assessmentofshort-termandlong-termriskfactorstoprovidethe neededguidance.
Short-termorimmediaterisk
Theshort-termorimmediateriskofadverseeventsinthe subse-quent30daysafterinitialpresentationhasbeenthefocusofseveral clinicalstudies(Table2).Thefindingsaresummarizedbrieflyhere andinTable2.
1)SanFranciscorule
Theriskfactorsidentifiedtobepredictiveofincreasedriskof adverseeventswithinthe7daysincluded[18]:
1)An abnormal electrocardiogram (ECG) (i.e. new rhythm changesornon-sinusrhythm).
Table2
Short-termrisk(1weekto1month).
Study Clinicalmarkers
SanFrancisco[18] AbnormalECG,lowbloodpressure,CHF,SOB, hematocrit<30%
Roserule[19] AbnormalECG,elevatedBNP,chestpain,fecalblood STePS[21] AbnormalECG,trauma,nowarning,malegender ECG,echocardiography;CHF,congestiveheartfailure;SOB,shortnessofbreath;BNP, brainnatriureticpeptide.
2)Systolicbloodpressure<90mmHg. 3)Hematocrit<30%.
4)Congestiveheartfailure(CHF)(eitherpresentatthetimeof initialpresentationorahistoryofCHF).
Theadverseeventsincludedtheoccurrenceofdeath, myocar-dial infarction, malignant arrhythmia, pulmonary embolism, stroke,subarachnoid hemorrhage,significant hemorrhage or otherseriouseventswhichrequiredreturntoEDand subse-quenthospitalization.
2)TheRoserule
Thiswasan ED-basedsingle center studyfromEdinburgh UKthat wasdesigned toidentify therisk factorspredictive ofanadverseeventwithin1-monthafterinitialpresentation to ED with syncope [19]. The adverse events were defined astheoccurrence ofdeath, acutemyocardial infarction, life-threateningarrhythmia,beingdiagnosedwithanyarrhythmia whichrequiredimplantationofacardiacpacemakeror defibril-latorwithinonemonth,pulmonaryembolism,cerebrovascular accident, hemorrhage or profound anemia requiring blood transfusion,andany returnstoEDwithin onemonth which requiredurgentsurgicalorendoscopicintervention.The find-ingsthatpredictedthelikelihoodofabove-mentionedadverse outcomesincluded:
1)Brainnatriureticpeptide>300pg/mL. 2)Stoolpositiveforoccultblood.
3)Oxygensaturation<94%onroomaironinitialpresentation. 4)Hemoglobin<90g/L.
5)Chestpainatthetimeofsyncope.
6)Bradycardia(heartrate<50beatsperminute).
Ofthestudypopulation,7.1%metwithanendpointattheend ofonemonth.ThesensitivityandspecificityofRoserulewere estimatedtobe87.2%and65.5%,respectively.
3)TheBostonstudy
Thisstudyincludedatotalof293patientswhowerefollowed for30daysaftertheirinitialpresentationtoEDwithsyncope, lookingforoccurrenceofadverseoutcomessuchasdeath, seri-ousillnessthatrequiredhospitalizationoracuteinterventions [20].
Sixty-eight(23%)patientsmetwithanadverseoutcome.The riskfactorsidentifiedinthisstudythatpredictedthelikelihood ofanadverseeventincludedthefollowing:
1)Acutecoronarysyndrome(ACS). 2)Conductionsystemdisease. 3)Historyofcardiacdisease. 4)Valvularheartdisease. 5)Familyhistoryofsuddendeath. 6)AbnormalvitalsignsinED. 7)Volumedepletion.
8)Primarycentralnervoussystemevent.
Thesensitivityandspecificityofthisstudyare97%and62%, respectively.
4)STePSstudy
A total of 676 patients were included in this study after screeningatotalof2700patientswithpresumedsyncope[21]. Theadverseoutcomeswithin10daysofinitialpresentationwith syncopewereassessed.Thestatisticallysignificantriskfactors predictiveofadverseoutcomeswere:
1)Age>65years. 2)Malegender.
3)Structuralheartdisease. 4)Heartfailure.
5)Trauma.
6)Absenceofsymptomsofimpendingsyncope. 7)AbnormalECG.
Thestudy,however,hadalowpositivepredictivevalueofonly 11–14%duetoalowrateofadverseevents.
Theabove-mentionedstudiestriedtoidentifytheriskfactors thatpredictedthelikelihoodofanadverseoutcome.Theriskfactors identifiedinthesestudiestendedtohaveahighsensitivitybut notspecificity.However,toidentifythehigh-riskpatientswhowill needprompthospitalizationuponinitialevaluation,theknowledge fromthesestudiescanbesummarizedasfollows.
High-riskmarkersofshort-termadverseoutcomes
Thefollowingriskfactorswerenotedtobeconsistently asso-ciatedwithincreasedriskofadverseoutcomesinallthestudies andwhenidentifiedaspartoftheinitialevaluationalmostalways resultinhospitalizationofthepatient.
1)ACSorsymptomssuggestiveofACSassociatedwithsyncopei.e. chestpainorshortnessofbreath.
2)EvidenceofCHFatthetimeofpresentationorahistoryofit. 3)Historyofstructuralheartdisease.
4)AbnormalECG. 5)Anemia.
6)Hemodynamicinstability.
TheESCguidelinesonmanagementofsyncopelistedthecriteria forhospitalizationofpatientspresentingwithsyncope. Hospital-izationofpatientsisadecisionthatshouldbemadecarefullyasone shouldbemindfulofnotonlypatientinconvenienceandanxiety butalsoahighlevelofavoidablehealthcareexpenditure.
Long-termrisk
Long-termriskisdefinedastheriskofanadverseeventinone yearorlongerafterinitialpresentationwithsyncope.Several stud-ieshaveattemptedtoestablishthelong-termriskfactors;several ofthesearesummarizedbelow.Table3summarizesthefindings fromthesestudies.
1)Martinetal.
Thisprospectivecohort studyfromtheUniversityof Pitts-burghconsistedoftwogroups [22].Thefirst groupincluded 252patientswithsyncope whoweremade apartof a risk-assessmentscheme(derivationcohort).Inthisgroup,thedata fromthepatient’shistory,physicalexamination,andECGdone intheEDwereusedtoidentifypredictorsofarrhythmiasor mor-talitywithinthefirstyear.Thesecondgroupconsistedof374 patientswithsyncopeinordertovalidatethesystem(validation cohort).Theobjectivewastoidentifythepredictorsofadverse outcomes(deathorseriousarrhythmias)at1-yearfollow-up. Fourmultivariateriskfactorswereidentifiedinthisstudy: 1)Abnormal ECG [odds ratio (OR) 3.2, 1.6–6.4] defined as
rhythm abnormalities, conduction disorders, hypertrophy, oldmyocardialinfarction,oratrioventricularblock.
2)Historyofventriculararrhythmia(OR4.8,1.7–13.9). 3)Historyofcongestiveheartfailure(OR3.1,1.3–7.4). 4)Age>45years(OR3.2,1.3–8.1).
Table3
Longer-term.
Study Clinicalmarkers
Martinetal.[22] AbnormalECG,CHF,SOB,ventriculararrhythmia,age >45years
OESILscore[23] AbnormalECG,age>65years,historyofcardiovascular disease,nowarning
EGSYS[24] Palpitationbeforeevent,abnormalECGorheart disease,syncopeduringeffort,syncopesupine ECG,echocardiography;CHF,congestiveheartfailure;SOB,shortnessofbreath.
Inpatientswithoutanyriskfactors,adverseeventswhichare definedasdeathorarrhythmiasoccurredin7.3% ofpatients inthederivationcohort and4.4%inthevalidationcohort.In patientswiththree tofourriskfactors,theabove-mentioned adverseeventsoccurredin80.4%ofpatientsinthederivation cohortand57.6%inthevalidationcohort.
2)STePSstudy
Atotalof676patientswereincludedinthisstudy[21]. Long-termadverseoutcomesweredefinedasdeathortheneedfor majortherapeuticprocedures.Adverseoutcomesoccurredin 9.3%ofthestudypopulationwhichincluded40(6%)deathsand 22patientsrequiringmajortherapeuticprocedures.
Five risk factors identified through a multivariate analysis wereassociated withadverseoutcomesin this study,which included:
1)Age>65years. 2)Historyofneoplasm. 3)Cerebrovasculardisease. 4)Structuralheartdisease. 5)Ventriculararrhythmia.
Mortalitywasnotedtobehigher(p<0.05)at1yearinpatients whowere admittedtothe hospital(14.7%) compared tothe patientswhoweredischarged(1.8%).
3)OESILstudy
Theriskfactorsidentifiedtobepredictiveof1-yearmortality inthisstudy[23]included:
1)Age>65years.
2)Historyofcardiovasculardisease. 3)Lackofprodromes.
4)AbnormalECGdefinedasrhythmabnormalities,conduction disorders,hypertrophy,oldmyocardialinfarction,possible acuteischemia,oratrioventricularblock.
One-yearmortalityinthisstudyincreasedprogressivelyfrom 0%inpatientswithnoneoftheabove-mentionedriskfactors,to approximately57%inpatientswith4riskfactors.
4)EGSYSscore
ThesixriskfactorsidentifiedintheEGSYSstudythatwere predictiveofadverseoutcomes[24]are:
1)Historyorevidenceofischemicheartdisease. 2)Valvularheartdisease.
3)Cardiomyopathy. 4)Congenitalheartdisease. 5)CHF.
6)Abnormal ECG (sinus bradycardia, atrioventricular block greaterthanfirstdegree,bundlebranchblock,acuteorold myocardialinfarction,supraventricularorventricular tachy-cardia, evidence of left or right ventricular hypertrophy, ventricularpreexcitation,longQT,orBrugadapattern). Themortalityat2yearswasnotedtobe2%inpatientswitha score<3and21%forascore>3.
Riskstratificationbasedoncardiacversusnon-cardiac causesofsyncope
Syncopefromacardiaccausehasbeennotedtobeassociated with both short- and long-term risk of adverse outcomes.The comparison ofmorbidityand mortalityinpatientswithcardiac syncopeandnon-cardiacsyncopehasbeenthesubjectofseveral studies.
1)Soteriadesetal.
Atotalof7814patientswereincludedinthisstudywhich evaluatedtheincidenceand prognosisamong participantsin theFraminghamheartstudyfrom1971to1998[25].Syncope occurredin822patients.Cardiaccausewasconsideredbythe
investigatorstobetheetiologyin9.4%andvasovagalin21.2%.In 36.6%thecauseofsyncoperemainedunknown.The multivari-atehazardratiosformortalityfromanycauseandstrokewere notedtobesignificantlyhigherinpatientswithpresumed car-diaccauseofsyncopewhencomparedtopatientswithsyncope fromothercauses.Thestudy,however,hadinherentweakness ofitsdiagnosticclassificationmainlyduetothelimitednature ofcollectedclinicalinformation.
2)Kapooretal.
Thisstudyassessedthemorbidityandmortalityattheendof5 yearsinatotalof433patientswhopresentedwithsyncope[26]. Initialhistory,physicalexamination,ECG,andprolongedcardiac monitoringwerehelpfulinassigningthecauseofsyncope,but onlyin22%ofthestudypopulation.Themortalityattheendof 5yearswasnotedtobesignificantlyhigher(50.5%)inpatients withcardiaccauseofsyncopewhencomparedtopatientswith non-cardiacorunknowncauseofsyncope(24.1%).Inaddition, theincidenceofsuddencardiacdeathwasnotedtobe signifi-cantlyhigher(33.1%)inpatientswithcardiaccauseofsyncope whencomparedtonon-cardiac(4.9%)orunknowncause(8.5%). 3)Ungaretal.
This recent study which included a relatively older set of patients(age66+20years)examinedtheriskofcardiovascular mortalityamongthepatientsenrolledinEvaluationof Guide-linesinSyncopeStudy2(EGSYS2)study[27].Atotal of380 patientswereincludedinthisstudywhichexaminedboth short-term(1month)andlong-term(2years)mortality.Atotalof35 (9.2%)deathsoccurredattheendof2years.Thedeathswere significantlyhigher(82%)inpatientswhowereolderandwho hadcardiacriskfactors,abnormalECGorahistoryofstructural heartdiseaseandsustainedinjuries relatedtosyncopewhen comparedtopatientswithoutabnormalECGorstructuralheart disease(3%).
4)Numerosoetal.
Inthisrecentstudyatotalof200patientspresentingwith syn-copewerefollowedtoevaluateincidenceofbothshort-term (1month)andlong-term(1year)adverseeventswhichwere definedasdeath,recurrenceofsyncope,cardiovascularevents, andmajorprocedures[28].Cardiacsyncopewasassociatedwith both greatershort-andlong-termoccurrence ofatleastone adverseevent.
Issyncopeamarkerofincreasedriskofcardiovascular morbidityandmortality?
Thisimportant question remains unresolved. A large recent population-basedstudy from Denmark [29] suggested that the occurrence of syncopein patientswithout anyprior history of co-morbiditiesmayconferanincreasedriskofcardiovascular mor-bidity and mortality. A total of 37,017 (median age 47 years) patientsadmittedtohospitalwithafirstsyncopeeventbetween 2001and 2009 were identified fromnationwide registries and approximatelyfivetimesthenumber(n=185,085)werechosen fromtheDanishpopulationascontrolsubjects(withoutsyncope) whowerematchedforageandsex.MultivariableCoxregression analysisdemonstrated a significantlyhigher all-causemortality andcardiovascularhospitalizationandeventrate(recurrent syn-cope,stroke,andplacementofICDorpacemaker)inpatientswith syncopewhencomparedtothecontrolsubjectswithoutsyncope. Thestudydidhaveamajorlimitationinthatthestudy popula-tionwashospitalizedpatientswithsyncopeandtheothercauses necessitatinghospitalizationwerenotcontrolled.Thefindingsin thisstudyhoweverdoemphasizetheimportanceofcarefulinitial evaluationofallpatientswithsyncopeandtheneedfordiligent riskstratification.
Table4
CriteriaforhospitalizationorintensiveevaluationbasedonEuropeanSocietyof Cardiology2009guidelines.
Severestructuralheartdiseaseorcoronaryheartdisease:
-Heartfailure
-Lowleftventricularejectionfraction -Previousmyocardialinfarction
Clinicalfeaturessuggestiveofarrhythmicsyncope:
-Syncopeinsupineposition -Syncopeduringexertion
-Palpitationsassociatedwithsyncope -Familyhistoryofsuddencardiacdeath
Electrocardiographicfindingssuggestingarrhythmicsyncope:
-Nonsustainedventriculartachycardia
-Bifascicularblock(leftbundlebranchblockorrightbundlebranchblock combinedwithleftanteriorofposteriorfascicularblock)
-OtherintraventricularconductionabnormalitieswithQRScomplex duration>120ms
-Inadequatesinusbradycardia(<50bpm)orsinoatrialblockinabsenceof negativechronotropicmedications(e.g.beta-blockersor
nondihydropyridinecalciumchannelblockers)orphysiologicbradycardia associatedwithphysicaltraining
-Pre-excitedQRScomplex -ProlongedorshortQTinterval
-RightbundlebranchblockpatternwithSTelevationinleadsV1–V3 (Brugadapattern)
-NegativeTwavesinrightprecordialleads,epsilonwavesandventricular latepotentialssuggestiveofarrhythmogenicrightventriculardysplasia
Importantco-morbidities:
-Severeanemia -Electrolyteabnormalities
Conclusion
Understandingthevariouscausesofsyncopeand differentiat-ingsyncopefromothercausesofTLOCarecriticalelementsinthe assessmentof patientswhopresent with‘collapse’. Inaddition, riskstratificationisanindispensablepartoftheinitialevaluation ofpatientspresentingwithsyncopeasitprovidesanopportunity to identify and protect the patients at immediate risk of life-threateningeventsbyprompthospitalization.Riskstratification, whenoptimal, alsoofferstheopportunitytoavoidunnecessary hospitalizationoflow-riskpatients,therebyreducingthe health-careexpenditure.Consequently,theneedtodevelopoptimalrisk assessmenttoolsandtrainfront-lineprovidersintheirusecannot beover-emphasized.
Atthepresenttime,whileaconsensusrisk-stratification instru-mentremainsinevolution, short-termriskstratificationstudies providecompellingevidencetohospitalizesyncopepatientswith a suspected cardiac cause (structural or arrhythmic). All the long-termstudiesunequivocally emphasizetheneedforcareful evaluationandmanagementofunderlyingheartdiseaseinthese patients.
Currently,the2009ESCTaskForceGuidelinesformanagement ofsyncopeprovideausefulandrelativelyup-to-datesummaryof currentcriteriaforhospitalization[1](Table4).Theseguidelines stronglyencouragethedevelopmentwithinmajormedical cen-tersofdedicated‘syncopeclinics,’staffedbyamultidisciplinary teamofinterestedmedicalprofessionals (cardiology,neurology, internalmedicine,psychiatry).Suchunitsmayactasaresourcefor acceleratingeffectiveassessmentofin-hospitalpatients,buteven moreimportantlyprovideareadilyaccessiblesitefortimely outpa-tientevaluationsofsyncope/collapsepatientswhodidnotrequire urgenthospitalization.
Acknowledgment
Thisworkwassupportedinpartbya grant fromtheEarlE BakkenFundforHeart–BrainResearchattheMinnesotaMedical Foundation.
References
[1]TaskForcefortheDiagnosisandManagementofSyncope,EuropeanSociety ofCardiology(ESC),EuropeanHeartRhythmAssociation(EHRA),HeartFailure Association(HFA),HeartRhythmSociety(HRS),MoyaA,SuttonR,AmmiratiF, MassinM,PepiM,PezawasT,RuizGranellR,SarasinF,UngarA,vanDijkJG, etal.Guidelinesforthediagnosisandmanagementofsyncope(version2009). EurHeartJ2009;30:2631–71.
[2]BlancJJ,BendittDG.Syncope:definition,classificationandmultiplepotential causes.In:BendittDG,BlancJJ,BrignoleM,SuttonRS,editors.The evalua-tionandtreatmentofsyncope.Ahandbookforclinicalpractice.Elmsford,NY: FuturaBlackwell;2003.p.3–10.
[3]VanDijkJG,ThijsRD,BendittDG,WeilingW.Aguidetodisorderscausing transientlossofconsciousness:focusonsyncope.NatRevMed2009;5:438–48.
[4]RyanDJ,NickS,ColetteSM,RoseanneK.Carotidsinussyndrome,should wepace?Amulticentrerandomizedcontrolledtrial(SAFEPACE2).Heart 2010;96:347–51.
[5]ParrySW,SteenN,BextonRS,TynanM,KennyRA.Pacinginelderlyrecurrent fallerswithcarotidsinushypersensitivity:arandomizeddouble-blind placebo-controlledcrossovertrial.Heart2009;95:405–9.
[6]KredietCT,ParrySW,JardineDL,BendittDG,BrignoleM,WielingW.Thehistory ofdiagnosingcarotidsinushypersensitivity:whyarethecurrentcriteriatoo sensitive?Europace2011;13:14–22.
[7]MathiasCJ.Autonomicdiseases:clinicalfeaturesandlaboratoryevaluation.J NeurolNeurosurgPsychiatry2003;74(Suppl.3):iii31–41.
[8]FreemanR, WielingW,AxelrodFB,BendittDG, BenarrochE,BiaggioniL, CheshireWP,ChelimskyT,CortelliP,GibbonsCH,GoldsteinDS,Hainsworth R,HilzMJ,JacobG,KaufmannH,etal.Consensusstatementonthe defini-tionoforthostatichypotension,neurallymediatedsyncopeandthepostural tachycardiasyndrome.ClinAutonRes2011;21:69–72.
[9]OlshanskyB,PooleJE,JohnsonG,AndersonJ,HellkampAS,PackerD,MarkDB, LeeKL,BardyGH,SCD-HeFTInvestigators.Syncopepredictstheoutcomeof cardiomyopathypatients:analysisoftheSCD-HeFTstudy.JAmCollCardiol 2008;51:1277–82.
[10]SchwartzLS,GoldfischerJ,SpragueGJ,SchwartzSP.Syncopeandsuddendeath inaorticstenosis.AmJCardiol1969;23:647–58.
[11]Chan-TackKM.Subclavianstealsyndrome:ararebutimportantcauseof syn-cope.SouthMedJ2001;94:445–7.
[12]PetersenME,WilliamsTR,SuttonR.Psychogenicsyncopediagnosedby pro-longedhead-uptilttesting.QuartJMed1995;88:209–13.
[13]KovacS,DiehlB.Atonicphenomenainfocalseizures:nomenclature,clinical findingsandpathophysiologicalconcepts.Seizure2012;21:561–7.
[14]BartolettiA,FabianiP,AdrianiP,BaccettiF,BagnoliL,BuffiniG,CappellettiC, CecchiniP,GianniR,LavacchiA,TicaliPF,SantoroGM.Hospitaladmissionof patientsreferredtotheEmergencyDepartmentforsyncope:asingle-hospital prospectivestudybasedontheapplicationoftheEuropeanSocietyof Cardiol-ogyGuidelinesonsyncope.EurHeartJ2006;27:83–8.
[15]BrignoleM,UngarA,CasagrandaL,GliziaM,LunatiM,AmmiratiF,DelRosso A,SasdelliM,SantiniM,MaggiR,VitaleE,MorrioneA,FranceseM,Vecchi
MR,GiuliS,etal.Prospectivemulticentresystematicguideline-based manage-mentofpatientsreferredtothesyncopeunitsofgeneralhospitals.Europace 2010;12:109–18.
[16]BendittDG,CanI.Initialevaluationof“syncopeandcollapse”theneedfora riskstratificationconsensus.JAmCollCardiol2010;55:722–4.
[17]ShenWK,DeckerWW,SmarsPA,GoyalDG,WalkerAE,HodgeD,TrustyJM, BrekkeKM,JahangirA,BradyPA,MungerTM,GershBJ,HammillSC,FryeRL. SyncopeEvaluationintheEmergencyDepartmentStudy(SEEDS).A multidis-ciplinaryapproachtosyncopemanagement.Circulation2004;110:3636–45.
[18]QuinnJV,StiellIG,McDermottDA,SellersKL,KohnMA,WellsGA.Derivation oftheSanFranciscoSyncopeRuletopredictpatientswithshort-termserious outcomes.AnnEmergMed2004;43:224–32.
[19]ReedMJ,NewbyDE,CoullAJ,PrescottRJ,JacquesKG,GrayAJ.TheROSE(risk stratificationofsyncopeintheemergencydepartment)study.JAmCollCardiol 2010;55:713–21.
[20]Grossman SA, Fischer C, Lipsitz LA, Mottley L, Sands K, Thompson S, ZimetbaumP,ShapiroNI.Predictingadverseoutcomesinsyncope.JEmerg Med2007;33:233–9.
[21]CostantinoG,PeregoF,DipaolaF,BorellaM,GalliA,CantoniG,Dell’OrtoS,Dassi S,FilardoN,DucaPG,MontanoN,FurlanR,STePSInvestigators.Short-and long-termprognosisofsyncope,riskfactors,androleofhospitaladmission:results fromtheSTePS(Short-TermPrognosisofSyncope)study.JAmCollCardiol 2008;51:276–83.
[22]MartinTP,HanusaBH,KapoorWN.Riskstratificationofpatientswithsyncope. AnnEmergMed1997;29:459–66.
[23]ColivicchiF,AmmiratiF,MelinaD,GuidoV,ImperoliG,SantiniM,OESIL (OsservatorioEpidemiologicosullaSincopenelLazio)Study Investigators. Developmentandprospectivevalidationofariskstratificationsystemfor patientswithsyncopeintheemergencydepartment:theOESILriskscore.Eur HeartJ2003;24:811–9.
[24]DelRossoA,UngarA,MaggiR,GiadaF,PetixNR,DeSantoT,MenozziC, BrignoleM.Clinicalpredictorsofcardiacsyncopeatinitialevaluationin patients referredurgently to a generalhospital: the EGSYS score. Heart 2008;94:1620–6.
[25]SoteriadesES,EvansJC,LarsonMG,ChenL,BenjaminEJ,LevyD.Incidenceand prognosisofsyncope.NEnglJMed2002;347:878–85.
[26]KapoorWN.Evaluationandoutcomeofpatientswithsyncope.Medicine (Bal-timore)1990;69:160–75.
[27]UngarA,DelRossoA,GiadaF,BartolettiA,FurlanR,QuartueriF,Lagi A, MorrioneA,MussiC,LunatiM,DeMachiG,DeSantoT,MarchionniN,Brignole M,EvaluationofGuidelinesofSyncopeStudy2Group.Earlyandlateoutcome oftreatedpatientsreferredforsyncopetoemergencydepartment:theEGSYS 2follow-upstudy.EurHeartJ2010;31:2021–6.
[28]NumerososF,MossiniG,LippiG,CervellinG.Evaluationofthecurrent progno-sticroleofcardiogenicsyncope.InternEmergMed2013;8:69–73.
[29]RuwaldMH, Hansen ML,Lamberts M,Hansen CM,Vinther M,Køber L, Torp-PedersenC,HansenJ,GislasonGH.Prognosisamonghealthy individ-ualsdischargedwith a primary diagnosisof syncope.J AmColl Cardiol 2013;61:325–32.